These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34421548)

  • 21. Dopamine transporters in the cerebellum of mutant mice.
    Giompres P; Delis F
    Cerebellum; 2005; 4(2):105-11. PubMed ID: 16035192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors.
    Ledonne A; Mercuri NB
    Front Cell Neurosci; 2017; 11():27. PubMed ID: 28228718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity and impact of adrenergic projections to the midbrain dopamine system.
    Mejias-Aponte CA
    Brain Res; 2016 Jun; 1641(Pt B):258-73. PubMed ID: 26820641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental pathways linked to the vulnerability of adult midbrain dopaminergic neurons to neurodegeneration.
    Prakash N
    Front Mol Neurosci; 2022; 15():1071731. PubMed ID: 36618829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
    Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
    Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular heterogeneity in the substantia nigra: A roadmap for understanding PD motor pathophysiology.
    Gaertner Z; Azcorra M; Dombeck DA; Awatramani R
    Neurobiol Dis; 2022 Dec; 175():105925. PubMed ID: 36372290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson's disease: a detailed PET analysis of 12 striatal subregions.
    Park SB; Kwon KY; Lee JY; Im K; Sunwoo JS; Lee KB; Roh H; Ahn MY; Park S; Kim SJ; Oh JS; Kim JS
    Neurol Sci; 2019 Feb; 40(2):311-317. PubMed ID: 30415448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive performance correlates with the degree of dopaminergic degeneration in the associative part of the striatum in non-demented Parkinson's patients.
    Kübler D; Schroll H; Buchert R; Kühn AA
    J Neural Transm (Vienna); 2017 Sep; 124(9):1073-1081. PubMed ID: 28643101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopaminergic contribution to the regulation of emotional perception.
    Salgado-Pineda P; Delaveau P; Blin O; Nieoullon A
    Clin Neuropharmacol; 2005; 28(5):228-37. PubMed ID: 16239763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences in dopaminergic system dysfunction in de novo Parkinson's disease clinical subtypes.
    Boccalini C; Carli G; Pilotto A; Padovani A; Perani D
    Neurobiol Dis; 2022 Jun; 167():105668. PubMed ID: 35219854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
    Weickert TW; Mattay VS; Das S; Bigelow LB; Apud JA; Egan MF; Weinberger DR; Goldberg TE
    Schizophr Res; 2013 Sep; 149(1-3):162-6. PubMed ID: 23830543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ophthalmic disorders as a manifestation of Parkinson's disease].
    Chesnokova NB; Pavlenko TA; Ugrumov MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(9):124-131. PubMed ID: 29053133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.
    Alex KD; Pehek EA
    Pharmacol Ther; 2007 Feb; 113(2):296-320. PubMed ID: 17049611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.
    Hilario WF; Herlinger AL; Areal LB; de Moraes LS; Ferreira TA; Andrade TE; Martins-Silva C; Pires RG
    J Mol Neurosci; 2016 Dec; 60(4):453-464. PubMed ID: 27660217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal Herpesviridae infection during pregnancy alters midbrain dopaminergic signatures in adult offspring.
    Burmeister AR; Gordevicius J; Paul EN; Houck C; George S; Escobar Galvis ML; Sha Q; Brundin P; Pospisilik JA; Racicot K; Brundin L
    Neurobiol Dis; 2022 Jul; 169():105720. PubMed ID: 35417751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual dopamine midbrain neurons: functional diversity and flexibility in health and disease.
    Liss B; Roeper J
    Brain Res Rev; 2008 Aug; 58(2):314-21. PubMed ID: 18023878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ghrelin on the motor deficit caused by the ablation of nigrostriatal dopaminergic cells or the inhibition of striatal dopamine receptors.
    Suda Y; Kuzumaki N; Narita M; Hamada Y; Shibasaki M; Tanaka K; Tamura H; Kawamura T; Kondo T; Yamanaka A; Narita M
    Biochem Biophys Res Commun; 2018 Feb; 496(4):1102-1108. PubMed ID: 29378186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.